28
Mar

AstraZeneca has struck up a partnership with the Shenzhen University Health Science Center in Shanghai to collaborate on preclinical work for chronic kidney disease treatments, a growing problem among China’s aging population.

…read more

Source: AstraZeneca looks to China for kidney disease R&D

    

0 No comments